Literature DB >> 15932388

Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization.

G Ciprandi1, G L Marseglia, C Klersy, M A Tosca.   

Abstract

BACKGROUND: Allergic rhinitis is associated with Th2-dependent inflammation. Nasal obstruction is the most typical symptom in children with mite allergy.
OBJECTIVES: The aim of this study was to evaluate the possible relationships among nasal symptoms, allergic inflammation, including inflammatory cells and cytokine pattern, and nasal airflow in children with persistent allergic rhinitis because of mite sensitization.
METHODS: Twenty children (13 males and seven females, mean age 13.4 +/- 1.6 years) with persistent rhinitis because of mite allergy were evaluated. All of them had moderate-severe grade of nasal obstruction. Total symptom score (TSS), rhinomanometry, nasal lavage, and nasal scraping were obtained in all subjects. Inflammatory cells were counted by conventional staining; interleukin (IL)-5, and IL-8 were measured by immunoassay on fluids recovered from nasal lavage.
RESULTS: Eosinophils were significantly associated with TSS (R = 74.4%, P = 0.0002), with IL-5 (R = 90.6%, P < 0.0001) and with nasal flow (R = -69%, P = 0.0007), but not with IL-8 (R = 0.1%, P = 0.995). Eosinophil levels were shown to independently predict nasal flow (P < 0.001), with flow decreasing linearly for increasing eosinophils, together with a significant effect of neutrophils (P = 0.016, linear increase in flow) and a borderline effect of IL-8 (P = 0.063, linear increase in flow).
CONCLUSIONS: This study demonstrates the close association between IL-5 concentration and eosinophil infiltration. In addition, there is clear evidence concerning the relationship between eosinophil infiltration and nasal airflow. Thus, nasal eosinophils can be regarded as the most important predictor of upper airway function. These findings constitute first evidence of the relationship between nasal airflow impairment and Th2-related eosinophilic inflammation in children with persistent allergic rhinitis because of mite sensitization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932388     DOI: 10.1111/j.1398-9995.2005.00664.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  Early-life mold and tree sensitivity is associated with allergic eosinophilic rhinitis at 4 years of age.

Authors:  Christopher D Codispoti; David I Bernstein; Linda Levin; Tiina Reponen; Patrick H Ryan; Jocelyn M Biagini Myers; Manuel Villareal; Jeff Burkle; Zana Lummus; James E Lockey; Gurjit K Khurana Hershey; Grace K LeMasters
Journal:  Ann Allergy Asthma Immunol       Date:  2015-03       Impact factor: 6.347

2.  Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice.

Authors:  Gian Franco Cupido; Matteo Gelardi; Ignazio La Mantia; Salvo Emanuele Aragona; Claudio Vicini; Giorgio Ciprandi; Italian Study Group On Inflammatory Otorhinolaryngological Disorders
Journal:  Acta Biomed       Date:  2019-07-10

Review 3.  Open and clean: the healthy nose.

Authors:  Giorgio Ciprandi; Matteo Gelardi
Journal:  Acta Biomed       Date:  2019-01-14

4.  Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine.

Authors:  Joaquim Mullol; Claus Bachert; Jean Bousquet
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

5.  Complementary treatment of allergic rhinoconjunctivitis: the role of the nutraceutical Lertal(R).

Authors:  Gianluigi Marseglia; Amelia Licari; Giorgio Ciprandi
Journal:  Acta Biomed       Date:  2020-03-19

6.  Nasal cytology identifies healthy and damaged nasal epithelial cells - Reply.

Authors:  Giorgio Ciprandi; Matteo Gelardi
Journal:  Acta Biomed       Date:  2020-03-19

7.  Functional alterations of the stomatognathic system in patients with allergic rhinitis: case-control study.

Authors:  Catiane Maçaira de Lemos; Niels Sales Willo Wilhelmsen; Olavo de Godoy Mion; João Ferreira de Mello Júnior
Journal:  Braz J Otorhinolaryngol       Date:  2009 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.